Article
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
Thoracic cancer - 1 Aug 2022
Metzenmacher Martin, Hegedüs Balazs, Forster Jan, Schramm Alexander, Horn Peter A, Klein Christoph A, Bielefeld Nicola, Ploenes Till, Aigner Clemens, Siveke Jens T, Schuler Martin, Lueong Smiths S
Abstract excerpt
BACKGROUND: CT scans are used in routine clinical practice for the diagnosis and treatment surveillance of non-small cell lung cancer (NSCLC). However, more sensitive methods are desirable. Liquid biopsy analyses of RNA and DNA can offer more sensitive diagnostic approaches. Cell-free RNA (cfRNA) has been described in several malignancies, but its clinical utility has not previously been explored. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
